/AGL

agilon health inc

AGL

$89.77USD↓-3.06%-2.83 today

MARKET CAP

1.5B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$89 – $97

52W RANGE

$7

$133

AI Summary

Stalk

TrimMedium

Price has decisively broken below the key support cluster and is trading under declining EMAs, confirming a medium-term bearish structure. Short-term timing is neutral as price consolidates around current support, so execution should be deferred to trim into rallies toward resistance zones.

↑Q2 revenue grew 7% YoY to $1.5B; medical margin turned positive at $197M vs –$53M prior.
↑Adjusted EBITDA of $70M in Q2 vs a –$83M loss last year.
↓Negative profitability factor and negative earnings yield raise valuation concerns.

Full analysis →

Buying

9

institutions

Selling

3

institutions

New Positions

6

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.15 M	122.88 M	+273.36 K	+1679.2%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	692.54 K	74.23 M	+-282.36 K	+862.5%	0.03%
CA Citadel Advisors LLC Q2 2026	BUY	184.57 K	19.78 M	+174.02 K	+23592.2%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	152.21 K	16.31 M	+3.17 K	+1283.8%	0.02%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	40.17 K	4.31 M	+40.17 K	+0.0%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	37.79 K	4.05 M	+-138.80 K	+190.0%	0.21%
MM Millennium Management LLC Q2 2026	BUYNEW	33.82 K	3.62 M	+33.82 K	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	26.02 K	2.79 M	+26.02 K	+0.0%	0.00%
VI Voloridge Investment Management, LLC Q2 2026	BUYNEW	24.24 K	2.60 M	+24.24 K	+0.0%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	14.86 K	1.71 M	+-13.83 K	+18456.9%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	8.46 K	906.31 K	+8.46 K	+0.0%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	BUYNEW	106.00	11.36 K	+106.00	+0.0%	0.00%